Map Key
Generic Enzyme
Generic kinase
Protein kinase
Lipid kinase
Generic phosphatase
Protein phosphatase
Lipid phosphatase
Generic phospholipase
Generic protease
Metalloprotease
G-alpha
RAS - superfamily
G beta/gamma
Regulators (GDI, GAP, GEF)
Generic channel
Ligand-gated channel
Voltage-gated channel
Transporter
Normal process
Pathological process
Positive effect
Negative effect
Unspecified effect
Technical link
Disrupts in disease
Emerges in disease
Enhances in disease
Weakens in disease
Organsim specific interaction

Generic binding protein
Receptor ligand
Cell membrane glycoprotein
Transcription factor
DNA
RNA
Compound
Inorganic ion
Predicted metabolite or user's structure
Reaction
Generic receptor
GPCR
Receptors with enzyme activity
Mitochondria
EPR
Golgi
Nucleus
Lysosome
Peroxisome
Cytoplasm
Extracellular

Normal process
Pathological process
Binding
Cleavage
Covalent modifications
Phosphorylation
Dephosphorylation
Transformation
Transport
Catalysis
Transcription regulation
MicroRNA binding
Competition
Influence on expression
Unspecified interactions
Pharmacological effect
Toxic effect
Group relation
Complex subunit
Similarity reaction
A complex or a group
Organism specific object

Development Alpha-2 adrenergic receptor activation of ERK


Log In to Post A Comment

Development Alpha-2 adrenergic receptor activation of ERK

Alpha-2 adrenergic receptor activation of ERK

Alpha-2A adrenergic receptor, Alpha-2B adrenergic receptor, andAlpha-2C-1 adrenergic receptor participate in activation of Mitogen-activatedprotein kinases 1 and 3 ( ERK1/2 ) via different ways [1].

Alpha-2A adrenergic receptor activates Phospholipase C beta 3 or 2 (PLC-beta3 or PLC-beta2) when complex Guanine nucleotide binding protein (Gprotein) beta and gamma ( G-protein beta/gamma ) is released from the trimericcomplex with G-protein alpha-i family (presumably by G-protein alpha-i2 )[2], [3]. PLC-beta3 and PLC-beta2 may to hydrolyzePhosphatidylinositol-4,5-Bisphosphate ( PtdIns(4,5)P2 ) and produce1,2-diacyl-glycerol ( DAG ) and Inositol 1,4,5-trisphosphate ( IP3 ).IP3 activates Inositol 1,4,5-triphosphate receptor type 3 ( IP3 receptor ),which causes Ca('2) release from intracellular compartments. As a result ofactivation of adrenergic receptor, elevated cytosolic Ca('2) levels lead toactivation of Calmodulin/ most likely Calcium/calmodulin-dependent protein kinaseII ( CaMK II )/ PTK2B protein tyrosine kinase 2 beta ( Pyk2(FAK2) )/v-src sarcoma viral oncogene homolog ( c-Src )/ SHC transforming protein 1 (Shc )/ Growth factor receptor-bound protein 2 ( GRB2 )/ son of sevenlesshomolog ( SOS )/ v-Ha-ras Harvey rat sarcoma viral oncogene homolog (H-Ras )/ v-raf-1 murine leukemia viral oncogene homolog 1 ( c-Raf-1 )/Mitogen-activated protein kinase kinase 1 and 2 ( MEK1 and MEK2 )/Erk [2].

Also, activation of ERK cascade by all three Alpha-2 adrenergicreceptors is accomplished by stimulation of Arachidonic acid production viaDAG. DAG is catalyzed by Diacylglycerol lipase alpha and beta ( DGL-alphaand DGL-beta ) to 2-arachidonoylglycerol, which gets converted byMonoglyceride lipase to Arachidonic acid. Arachidonic acid is thenconverted by Cytochrome P450 (by, for instance, Cytochrome P450 family 2 subfamily Cpolypeptide 8 ( CYP2C8 )) to 14,15-epoxyeicosatrienoic acid ( 14,15-EET ),which activates c-Src. c-Src may phosphorylate matrix metalloproteinases, forexample ADAM metallopeptidase domain 12 ( ADAM12 ). ADAM12, in turn,cleaves Heparin-binding EGF-like growth factor ( HB-EGF ) leading totransactivation of Epidermal growth factor receptor ( EGFR ). EGFR thenactivates Shc- and GRB2 -mediated ERK cascade activation [1].

In addition, Alpha-2A and Alpha-2C-1 adrenergic receptors, afteractivation of c-Src, can activate Shc/ GRB2/ SOS withoutEGFR-transactivation [1].

Also, all three Alpha-2 adrenergic receptors stimulate v-akt murine thymomaviral oncogene homolog ( AKT(PKB )) that is thought to activate ERK2 andERK1. AKT(PKB ) may act via EGFR/ Phosphoinositide-3-kinase (PI3K)/ PtdIns(3,4,5)P3/ possibly via GRB2-associated binding protein 1 (GAB1 ) or directly/ 3-phosphoinositide dependent protein kinase-1 ( PDK(PDPK1 )/ AKT. Alpha-2A and Alpha-2C-1 adrenergic receptorsare also able to activate Phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) (PI3K reg class IA (p85-alpha) ) via c-Src without EGFRtransactivation [4], [5], [1].

Moreover, Alpha-2B adrenergic receptor participates in ERK activationvia extracellular Ca('2+) dependent Phospholipase A2 ( cPLA2 ) activation,which in turn lead to Arachidonic acid production and to the above-describedERK cascade activation via Shc [6].

Due to ERK activity, adrenergic receptors influence cell growth andproliferation [6], [1]. Furthermore, in nerve cells, ERKactivates Jun oncogene ( c-Jun ) and participates in cell differentiation [7].